What I would say is that when we talk about genetically modified organisms—of course, my interest is in genetically modified animals in particular—it raises a number of issues, some of which are ethical, some of which are environmental, some of which are on human health and some of which have to do with animals, so I think that the question that you've raised really crosses all of those boundaries.
Certainly I think that there is room in CEPA for the minister to take a more comprehensive approach to evaluating these products. We haven't specifically advocated for one approach or another, although I understand that the Senate did pass the amendment that you spoke to.
What I would say about part 6 is that for all of these reasons, I think that most stakeholders agree that we need a comprehensive review of that part. I understand that we are not doing it right now, which is disappointing, and it's also challenging, because we have these specific amendments the Senate put forward, and the question is if we keep those in now or we hold off in terms of a broader view. I think that, for the most part, the Senate's amendments start to move us in the right direction, and, as I mentioned in my brief, we additionally would like to see some regulation-making authority for animals.